Our development pipeline is focused in areas where stable isotope tracer methodology and early-stage kinetic modelling have shown our treatment candidates to have a high likelihood of providing a better treatment than any treatment currently available. We use complex metabolic substrates to provide a metabolic foundation for treatment that allows us to target diseases and symptoms that traditional medicines have been unable to treat. View the progress of our clinical pipeline below and click on any therapeutic area to learn more.